Jay S. Duker - 20 Feb 2024 Form 4 Insider Report for EyePoint Pharmaceuticals, Inc. (EYPT)

Signature
/s/ Ron Honig, Attorney-in-Fact
Issuer symbol
EYPT
Transactions as of
20 Feb 2024
Net transactions value
$0
Form type
4
Filing time
22 Feb 2024, 17:08:48 UTC
Previous filing
13 Feb 2024
Next filing
28 Feb 2024

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction EYPT Common Stock Gift $0 -20,000 -39% $0.000000 31,920 20 Feb 2024 Direct F1
transaction EYPT Common Stock Gift $0 +20,000 $0.000000 20,000 20 Feb 2024 Family Trust F1, F2
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 On February 20, 2024, the reporting person transferred owned shares of Common Stock of the Company to the Family Trust.
F2 These securities are held in a trust for the benefit of the reporting person's children. The reporting person's spouse is trustee of the Family Trust. The reporting person disclaims beneficial ownership of these securities and the filing of this report is not an admission that the reporting person is the beneficial owner of these securities for purposes of Section 16 or for any other purpose.